Sunway Healthcare IPO: Is RM1.45 Fairly Priced For Retail Investors?
ADVERTISEMENT
Sunway Healthcare Holdings Berhad is heading to Bursa Malaysia’s Main Market with a highly anticipated IPO priced at RM1.45 per share, in what is set to be Malaysia’s largest listing in almost a decade.
The deal raises up to about RM2.86 billion and values the group at roughly RM16–16.8 billion, giving investors exposure to one of the country’s largest private hospital operators—but at a premium valuation that leaves limited immediate upside based on published fair value estimates.
Sunway Healthcare IPO At A Glance
Sunway Healthcare is the healthcare arm of Sunway Berhad and operates a network of tertiary and quaternary hospitals anchored by Sunway Medical Centre in Sunway City, one of the largest private hospitals in Malaysia.
The IPO will see 1.97 billion shares offered at RM1.45 each, implying a market capitalisation of around RM16.7 billion and total proceeds of about RM2.86 billion, making it Malaysia’s biggest IPO in roughly nine years.
| Item | Details | Source | Notes |
|---|---|---|---|
| IPO Price | RM1.45 per share | The Star, Reuters | Final institutional & retail price |
| Offer Size | ≈1.97 billion shares | MarketScreener | New + existing shares |
| Estimated Proceeds | Up to ≈RM2.86 billion | The Star, MyBusinessTimes | Largest Malaysian IPO in years |
What Will The IPO Funds Be Used For?
A significant portion of the proceeds will go towards expanding Sunway Healthcare’s hospital network, including brownfield expansions and new medical centres that are expected to increase total bed capacity from around 1,800 licensed beds currently to over 3,400 by 2032.
The group will also use part of the funds to redeem Sukuk Wakalah and cover listing-related expenses, which should help reduce future finance costs and strengthen its balance sheet as it pursues regional growth ambitions.
Valuation: Is RM1.45 Expensive?
Based on IPO data compiled by local research platforms, Sunway Healthcare is listing at a hybrid price-to-earnings multiple of around 76 times, which is more than double the valuation of established peers like IHH Healthcare and KPJ Healthcare that trade in the mid‑30s.
This premium reflects expectations of strong long-term growth, medical tourism exposure and faster earnings ramp-up for new centres, but it also means the margin for error is small if earnings disappoint or expansion is delayed.
📖 Want a refresher on basic share trading before you jump into IPOs? Read our beginner’s guide on how to Minimize Trading Fees When Buying Stocks →
Target Price And Analyst Views
One widely cited IPO note assigns Sunway Healthcare a fair value of RM1.51 per share, implying only about 4.1% upside from the IPO price of RM1.45, based on an enterprise value-to-EBITDA multiple of 25.5 times applied to forecast FY2027 EBITDA of RM673.3 million.
The same research expects a three‑year earnings compound annual growth rate of roughly 12–13%, supported by hospital expansions, sustained medical tourism demand and Malaysia’s ageing population, positioning the stock more as a defensive compounder than a quick multi‑bagger.
How Sunway Healthcare Compares With Peers
| Company | Segment | Indicative PE | Key Strength | Key Risk |
|---|---|---|---|---|
| Sunway Healthcare (IPO) | Private hospitals | ≈76x hybrid PE | Aggressive bed expansion; strong flagship asset | High valuation premium vs peers |
| IHH Healthcare | Regional hospitals | ≈34.5x PE | Diversified regional presence | Currency & policy risks |
| KPJ Healthcare | Malaysia-focused hospitals | ≈35.5x PE | Established local franchise | Competitive domestic market |
ADVERTISEMENT
Example: What Does A Small Application Look Like?
To visualise potential outcomes, imagine a retail investor applying for 5,000 shares in the Sunway Healthcare IPO at RM1.45 per share, for a total application amount of RM7,250 before fees.
| Scenario | Assumed Listing Price | Paper Gain / (Loss) |
|---|---|---|
| Target price hits RM1.51 | RM1.51 (fair value) | ≈RM300 gain (before costs) |
| Bullish debut at RM1.70 | RM1.70 | ≈RM1,250 gain (before costs) |
| Weak debut at RM1.30 | RM1.30 | ≈RM750 loss (before costs) |
These simple scenarios show that with a relatively small spread between IPO price and published fair value, your short‑term outcome will depend heavily on listing‑day sentiment and actual demand rather than the target price alone.
Key Takeaways For Retail Investors
Sunway Healthcare’s IPO offers access to a fast-growing private hospital group with strong branding, expansion visibility and demographic tailwinds, but that growth story is already reflected in a premium valuation relative to peers.
With fair value estimates only slightly above the IPO price, the deal looks more suitable for investors comfortable holding a defensive healthcare name over the long term rather than those purely chasing a large short‑term listing pop.
💡 Pro Tip: If you missed the IPO balloting, you can still buy Sunway Healthcare shares on the listing day through your preferred broker. Before you do, use our MY brokerage comparison calculator → to estimate your brokerage costs and compare which platform gives you the lowest fees.
ADVERTISEMENT
Final Thought
If you decide to participate in the Sunway Healthcare IPO, treat it as part of a diversified portfolio and be realistic about the limited discount to fair value—high‑quality names can still disappoint if you overpay for growth.
⚠️ Important Disclaimer
This article is for informational purposes only and does not constitute financial advice.
- The information above is based on publicly available sources believed to be reliable at the time of writing.
- Past performance and projections are not guarantees of future results.
- All investments involve risk, including the possible loss of principal.
- Always read the full prospectus and do your own research before investing.
- Consult a licensed financial advisor for personalised investment advice.
Duitwise does not take responsibility for any investment decisions made based on this article.
References
- The Star – “Sunway Healthcare sets its institutional and final retail IPO price at RM1.45”
- MarketScreener – “Sunway Healthcare Eyes $4.3 Billion Market Cap in Malaysia's Biggest IPO Since 2017”
- Reuters – “Sunway Healthcare sets final price for $722 million IPO, Malaysia's largest in nine years”
- iSaham – “IPO Insights: Sunway Healthcare Holdings Berhad (SUNMED)”
- Malacca Securities via Moomoo – “Sunway Healthcare Assigned Modest Fair Value Of 4.1% Over IPO Price”
- iSaham Blog – “Analisis IPO Sunway Healthcare Berhad”